Sign inJoin waitlistJoin the waitlist

VP

Vijay Peddareddigari

Hematology

Credentials: · · ·

History

Hematology and Medical Oncology
University of Texas M D Anderson Cancer Center
2007–2010
Internal Medicine
Jefferson Health Medical Education
2004–2007
Doctor of Medicine
2000–2004

Research

Safety, pharmacokinetic, pharmacodynamic, and efficacy data for the oral MEK inhibitor trametinib: a phase 1 dose-escalation trial
The Lancet Oncology · 2012 · 478 citations
Activity of the oral MEK inhibitor trametinib in patients with advanced melanoma: a phase 1 dose-escalation trial
The Lancet Oncology · 2012 · 448 citations
Phase I Dose-Escalation Study of JNJ-42756493, an Oral Pan-Fibroblast Growth Factor Receptor Inhibitor, in Patients With Advanced Solid Tumors
Journal of Clinical Oncology · 2015 · 324 citations

JI
Jeffrey Infante
4 papers
GF
Gerald Falchook
2 papers
HB
Howard Burris
2 papers
JB
Johanna Bendell
2 papers
Keith Flaherty
2 papers
LF
Leslie Fecher
2 papers
Michael Gordon
2 papers
Razelle Kurzrock
2 papers
Wells Messersmith
2 papers
AM
Alain Mita
1 paper
AW
Andrew Whiteley
1 paper · 1 as a fellow
Anja Roden
1 paper